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SUMMARY 
The inter-laboratory study regarding tetracyclines in poultry muscle was performed following ISO/IEC 
Guide 43-1 and 43-2.  
 
For the inter-laboratory study regarding tetracyclines in poultry muscle, three test materials were 
prepared: 
• A blank material (A); 
• A material containing oxytetracycline and 4-epioxytetracycline, the sum of both being just 
above the MRL and doxycycline at about 0.5*MRL (B); 
• A material containing an amount of oxytetracycline and doxycycline just above the MRL (C). 
Homogeneity and sufficient stability of the materials was demonstrated. 
 
Seventeen laboratories were invited to participate in the inter-laboratory study for tetracyclines in 
poultry muscle of which sixteen laboratories, i.e. 94%, subscribed. 
Each laboratory received six randomly coded samples including two duplicates of materials A, B and C. 
The laboratories were asked to analyze the samples in duplicate, resulting in four results for each 
material. 
 
Eleven participating laboratories reported their results. The results of those laboratories were included in 
the report without any modifications. Two laboratories analysed the samples for oxytetracycline only. 
Five laboratories notified RIKILT not being able to participate due to different reasons.  
 
The majority of the laboratories extracted the poultry muscle samples using an EDTA-McIlvain buffer. 
By far the most common sample clean-up procedure is Solid Phase Extraction (SPE) using a polymer 
based material (e.g. OASIS® HLB). Most of the participants used LCMS/MS for the confirmatory 
analysis. Two laboratories applied LCDAD as a confirmatory technique.  
Four of the participating laboratories include 4-epiOTC, 4-epiTC and 4-epiCTC in their analysis. Those 
laboratories comply with the definition of the MRL as stated in the Commission Regulation No. 281/96 
[11]. The laboratories that have those 4-epitetracyclines included in their method cope in different ways 
regarding the quantification of these analytes.  
 
Most participating laboratories determined values for CCα and CCß and, hence, the majority already 
complies with Commission Decision 2002/657/EC regarding the way to report results for registered 
veterinary drugs as from the 1st of August 2007 [16].  
For some laboratories the reported values for CCα and CCß are not in agreement with the 
reproducibility of the analysis calculated from the reported results in this inter-laboratory study.  
 
In this inter-laboratory study, both false negative and false positive results occurred.   
 
The calculated assigned value of material B is 104 µg/kg 4-epiOTC + OTC and 53 µg/kg DC, with an 
uncertainty of 12 µg/kg and 1.4 µg/kg respectively. The uncertainty of the assigned value of  4-epiOTC 
+ OTC in this material is quit high (above 0.3σp). 
Although, all participants reported satisfactory results with regard to the accuracy for both 4-epiOTC + 
OTC and DC, it is stated that a considerable variation is observed for the reported amount of 4-epiOTC 
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+ OTC (average results ranging from 63.5 to 146.7 µg/kg). One laboratory reported results with a 
questionable reproducibility.  
 
The calculated assigned value of material C is 141 µg/kg OTC and 181 µg/kg DC, with an uncertainty 
of 10 µg/kg for both analytes. The uncertainty of the assigned value of OTC in this material is quit high 
(above 0.3σp). 
82% of the participants reported satisfactory results with regard to the accuracy of OTC. A considerable 
variation is observed for the reported amount of OTC in this material (average results ranging from 85.5 
to 231.5 µg/kg).   
For DC, all laboratories reported satisfactory results.  
 
The performance regarding accuracy, reproducibility, false positives and false negatives was expressed 
in a laboratory performance score for each laboratory. 72% of the laboratories obtained the maximum 
score. 
 
Although most laboratories obtained satisfactory results regarding the accuracy and the reproducibility, 
it is concluded that extra effort is needed regarding the analysis of tetracyclines in poultry muscle: 
• 4-epiOTC, 4-epiTC and 4-epiCTC should be included in the method for the analysis of 
tetracyclines by all laboratories; 
• Reconsideration of values determined for CCα and CCß with respect to their accuracy may be 
necessary in some case; 
• An effort should be made regarding the quantitative analysis of especially OTC in poultry 
muscle; 
• Some laboratories should make an effort to prevent false positives and false negatives in the 
future. 
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1 INTRODUCTION 
1.1 Inter-laboratory testing 
Inter-laboratory testing is conducted to provide laboratories with a powerful tool to evaluate and 
demonstrate the reliability of the data that is produced. Next to validation and accreditation, inter-
laboratory testing is an important requirement of the EU Additional Measures Directive 93/99/EEC [1] 
and is increasingly important in the revised draft ISO 17025 [2].  
The aim of this inter-laboratory study was to give laboratories the possibility to evaluate or demonstrate 
their competence for the analysis of tetracyclines in poultry muscle. This study also provided an 
evaluation of the methods applied for quantitative and confirmatory analysis of tetracyclines. 
The inter-laboratory study was carried out according to guidelines ISO/IEC 43-1 [3] and ISO/IEC 43-2 
[4]. 
1.2 Tetracyclines in poultry muscle 
Tetracyclines are a very important group of antibiotic agents in human and veterinary medicine. 
Oxytetracycline (OTC), tetracycline (TC), chlortetracycline (CTC) and doxycycline (DC) are the most 
well known tetracycline compounds. 
 
CTC and OTC are produced by Streptomyces aureofaciens and Streptomyces rimosus respectively. TC 
is produced semisynthetically from CTC. DC is a semisynthetic derivate [5, 6].  
 
Tetracyclines have a broad-spectrum activity which includes Gram-positive and Gram-negative 
bacteria. They interfere with the bacterial protein synthesis in rapidly growing and reproducing bacterial 
cells and inhibit the metabolism of the bacteria by interfering with the protein synthesis [5, 6].  
 
Tetracyclines have a clinical application in the treatment of rickettsia and colibacillosis. At the 
beginning of administration success in combating infections is remarkable but in due course a resistance 
is built up and the effect may be reduced to zero [5-7].  
The toxicity of tetracyclines is low, but after prolonged therapy or contact, infections with resistant 
organisms, allergic reactions and vitamin B deficiencies may occur. The use of tetracyclines during 
pregnancy and by young children and animals has adverse effects on skeleton formation [7]. 
In addition to the antibiotic use, tetracyclines are applied as growth-stimulants and as preservatives to 
lengthen the shelf-life of poultry and meats [7].  
 
After oral administration adequate absorption of the tetracyclines takes place and they can persist at 
high concentrations [5]. Absorption of tetracycline is impaired by milk products, calcium and 
magnesium salts, and iron preparations. The mechanisms responsible for decreased absorption appear to 
be chelation and an increase in pH [6]. After absorption, tetracyclines are widely distributed in the body, 
with the highest concentrations in liver and kidney.  
The metabolism of tetracyclines was extensively studied in several species including dogs and rats [6]. 
The results indicated that, with the exception of metal chelate formation, no chemical transformation 
occurred in the body. Small amounts of 4-epimers were detected. This was contributed to chemical 
instability at physiological conditions rather than to metabolic transformation [6].  
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According to EU regulations, all substances for veterinary use need to be included in Annexes I, II or III 
of Council Regulation (ECC) No 2377/90. Tetracyclines are included in Annex I: pharmacologically 
active veterinary products for which a Maximum Residue Limit (MRL) is established.  The MRL for 
OTC, TC and CTC is established as the sum of the tetracycline and its 4-epimer and is 100 µg/kg in 
muscle for all food producing species. For DC, the MRL is established at 100 µg/kg in muscle tissue for 
DC only for all food producing species [8-10].  
 
This inter-laboratory study focuses on OTC, 4-epiOTC and DC only. The structure of OTC, 4-epiOTC 
and DC are presented in figure 1.  
 
OH O OH
OH
O
OH
OHOHCH3
O
N
CH3CH3
NH2     OH O OH
OH
O
OH
OHOHCH3
O
N
CH3CH3
NH2  
b a 
 
OH O OH
OH
O
OH
OHCH3
O
N
CH3CH3
NH2  
c 
Figure 1. Molecular structure of (a) oxytetracycline, (b) 4-epioxytetracycline and (c) doxycycline. 
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2 TEST MATERIALS 
2.1 Sample preparation 
Three materials were prepared at different concentrations of OTC, 4-epiOTC and DC by adding 
solutions of OTC, 4-epiOTC and DC to blank poultry muscle. The materials were homogenised under 
cryogenic conditions. The materials presented in table 1 were obtained. 
 
Table 1.Target amount of tetracyclines in the inter-laboratory test materials  
Material code Amount of OTC (µg/kg) Amount of DC (µg/kg) 
A Blank Blank 
B Just above MRL* Just below MRL 
C Just above MRL About twice the MRL 
* Contains both OTC and 4-epiOTC. 
2.2 Sample identification 
Materials A, B and C were stored in containers containing at least 20 grams of muscle, yielding a total 
of 60 containers per batch. Per material, 20 randomly chosen containers were used for homogeneity and 
stability testing. The other samples were randomly coded with a code from TETRA/2005/001 through 
TETRA/2005/150.  
Twenty sets consisting of two samples of each material were randomly prepared as presented in 
Appendix I.  
2.3 Homogeneity study 
Ten containers of materials B and C were each analyzed in duplicate for OTC, TC, CTC, their 4-epimers 
and DC for the determination of the homogeneity of the materials. The homogeneity study was carried 
out according to The International Harmonized Protocol for Proficiency Testing of Analytical 
Laboratories [11] and ISO/DIS 13528 [12], taking into account the insights discussed by Fearn et al. 
[13] and Thompson [14]. 
The results of the homogeneity study and their statistical evaluation is presented in Appendices II and III 
for materials B and C respectively.  
All materials were demonstrated to be sufficiently homogeneous for use in inter-laboratory trials. 
Simultaneous with the analysis of each of the materials, at least two samples of material A were 
analyzed. Those analyses demonstrated that the material was free of tetracycline residues (< 10 µg/kg) 
and is therefore suited to use as a blank material in the inter-laboratory study. 
2.4 Sample distribution 
Each of the participating laboratories received a randomly assigned laboratory code. The sample sets 
with the corresponding number, consisting of six coded samples, were sent to the participating 
laboratories in the beginning op Arpil. The sample sets were packed in an insulating box, containing dry 
ice and were dispatched to the participants immediately by courier.  
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The samples were accompanied by a letter describing the requested analyses, an acknowledgement of 
receipt form and a results form. The laboratories were asked to analyse each of the samples in duplicate, 
resulting in four results for each material. The deadline for sending in results was established at the 1st of 
June, allowing seven weeks for analysis. Receipt of the samples in good condition (frozen) was 
confirmed by all participants except for laboratory 10. Due to some shipment difficulties, the samples of 
laboratory 10 did only arrive after six days. The laboratory reported that the samples arrived thawed. A 
new set (set No. 17 in Appendix I) was sent to the laboratory on the 19th of April. This sample set did 
arrive in good condition.    
2.5 Stability 
From the homogeneity data, the amount of tetracycline residues in the materials, just after preparation, 
is calculated from the average of the 20 results.  
The materials were stored at -80 °C until the 17th of May. On this day, 71 days after the initial analysis, 
three containers of material B and C were analysed. After this, the containers were stored at -20 degrees. 
On the 31st of May, 85 days after the initial analysis and at the end of the proficiency test, the containers 
were analysed again. For both points of time, the average of the results was calculated.  
The results of the initial analysis were compared to the results of the 17th and 31st of May, using a 
Students t-test [15]. The hypothesis for this test is: 
 
d00 xx:H =  
 
 where:  x0 = the average of the initial analysis;  
  xd = the average of the analysis at time=d. 
 
The standard deviation of both populations are considered the same, because the same analytical 
procedure is applied to obtain the results. Therefore the value t is calculated by: 
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  where: s = pooled standard deviation; 
     n0 = number of results of the initial analysis; 
     nd = number of results of the analysis at time=d; 
s0 = standard deviation of the initial analysis calculated from the 
CV% resulting from the validation procedure; 
 sd = standard deviation of the analysis at time=d calculated from 
the CV% resulting from the validation procedure. 
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The calculated value t is compared to a critical value (tcrit) derived from a table with t having n0+nd-2 
degrees of freedom [15]. If t < tcrit it is demonstrated that no significant difference between the average 
amount of the analysis at time=d and the initial analysis at time=0 is found. In this case the material is 
considered stable.  
 
The results and statistical evaluation of the stability test are presented in appendix IV. It was 
demonstrated that no significant loss of 4-epiOTC, OTC or DC occurred during the timescale of the 
inter-laboratory study at the chosen storage conditions. 
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3 APPLIED METHODOLOGIES 
The participating laboratories applied different sample preparation methods and detection techniques for 
the analysis of tetracyclines in poultry muscle. A schematic overview of the methods applied is 
presented in Appendix V. 
 
The majority of the participants extracted the poultry muscle samples using an aqueous and slightly 
acidic extraction medium. An EDTA-McIlvain buffer is the most general applied medium. Others are a 
sodium succinate solution, acetonitril and heptane, or a trichloroacetic acid solution. 
By far the most common sample clean-up procedure is Solid Phase Extraction (SPE) using a polymer 
based phase like OASIS® HLB. In one case this step is preceded by a clean-up using a chelated 
sepharose column loaded with copper ions. Two participants used a C18 based material for the SPE 
procedure. Two participants only filtered their extract before analysis without further purification.  
 
Most of the participants used LCMS/MS for the confirmatory analysis. Two laboratories applied 
HPLCDAD for their confirmatory method. This is in accordance with Commission Decision 
2002/657/EC [16] regarding the identification of detected compounds. For one laboratory the 
confirmatory analysis (LCMS/MS) was preceded by a quantitative analysis using HPLCUV. One 
laboratory did not confirm the identity of the analytes but merely carried out a quantitative analysis.  
 
Four laboratories used an internal standard for their quantitative analyses. In three cases demeclocycline 
(demethylchlortetracycline) was used.  
 
A majority of the participating laboratories included OTC, TC, CTC and DC in their analysis. One 
laboratory tested for OTC only.  One laboratory did not include DC in their method. The number of 
analytes included in the method is dependant on regional differences and could therefore be related to 
differences in registration of tetracyclines for veterinary use. 
Only four of the participating laboratories did pay specific attention to the presence of 4-epiOTC, 4-
epiTC and 4-epiCTC. Two other laboratories include just one of the 4-epimers in their method. These 
laboratories report several ways of coping with the quantitative analysis of 4-epiOTC: 
• In most cases 4-epiOTC co-elutes with OTC. In this case the sum of 4-epiOTC and OTC is 
quantified using OTC calibrants. 
• In some cases 4-epiOTC and OTC are chromatographically separated. Some laboratories 
quantify these compounds using separate calibrants for both 4-epiOTC and OTC. Others 
quantify the sum of both compounds using OTC calibrants. 
For some laboratories 4-epiOTC and OTC coelute, especially at low retention times. It could well be 
possible that some laboratories that do not pay specific attention to 4-epiOTC, did include 4-epiOTC in 
the quantitative analysis because of this without knowing.  
It is noted that the analysis of 4-epimers of tetracyclines is not yet generally applied. Seven of the eleven 
participating laboratories (i.e. 63%) do not fully comply with Commission Regulation No. 281/96 [10] 
regarding the definition of the MRL (inclusion of the 4-epimers). 
 
An overview of the method performance of the participating laboratories is presented in Appendix VI. 
Amongst the participating laboratories, four did not report values for CCα and CCß. Hence, not all 
participating laboratories are yet ready to report their results as required by Commission Decision 
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2002/657/EC [16] regarding CCα and CCß that apply for registered veterinary drugs as from the 1st of 
August 2007.  
It is noted that some laboratories (No. 1 and 12) report relatively low values for CCα. This suggests very 
good method reproducibility. Laboratory 10, on the other hand, reports relatively high values for CCα 
and CCß for DC, indicating variable method performance for this compound. 
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4 STATISTICAL EVALUATION 
The statistical evaluation was carried out according to the International Harmonized Protocol for the 
Proficiency Testing of Analytical Laboratories [11], elaborated by ISO, IUPAC and AOAC and ISO/DIS 
13528 [12] in combination with the insights published by the Analytical Methods Committee [17, 18] 
regarding robust statistics. 
4.1 Calculation of the assigned value 
The assigned value (X) was determined using robust statistics [14, 17, 18]. The advantage of robust 
statistics is that all values are taken into account: outlying observations are retained, but given less 
weight. Furthermore, it is not expected to receive normally distributed data in an inter-laboratory 
proficiency test. When using robust statistics, the data does not have to be normally distributed, which is 
necessary for applying classical outlier elimination methods. 
The robust mean of the reported results of all participants was calculated as the assigned value. 
4.2 Calculation of the uncertainty of the assigned value 
The uncertainty of the assigned value is calculated to determine the influence of this uncertainty on the 
evaluation. A high uncertainty of the assigned value will lead to a high uncertainty of the calculated 
participants za-scores. If the uncertainty of the assigned value and thus the uncertainty of the za-score is 
high, the evaluation could indicate unsatisfactory method performance without any cause within the 
laboratory. 
In other words, is it legitimate to draw any conclusion regarding the performance of the participating 
laboratories from the calculated assigned value and za-scores? 
The uncertainty of the assigned value (the robust mean) is calculated from the estimate of the standard 
deviation of the assigned value and the number of values used for the calculation of the assigned value: 
 
n
σu =  
 
 where u = uncertainty of the assigned value;  
  n = number of values used to calculate the assigned value;  
    σ = The estimate of the standard deviation of the assigned value resulting from robust 
statistics. 
 
According to ISO/DIS 13528 [12] the uncertainty of the assigned value is negligible and therefore does 
not have to be included in the statistical evaluation if: 
 
pσ3.0u≤  
 
 where u = The uncertainty of the assigned value; 
  σp  = target standard deviation (§ 4.3) 
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In case the uncertainty of the assigned value does not comply with this criterion, the uncertainty of the 
assigned value should be taken into account when evaluating the performance of the participants 
regarding the accuracy. 
4.3 Calculation of the target standard deviation 
According to Commission Decision 2002/657/EC [16], the inter-laboratory coefficient of variation for 
the repeated analysis of a reference or fortified material, under reproducibility conditions, shall not 
exceed the level calculated by the Horwitz equation. 
The Horwitz equation, σH = 0.02c0.8495 presents a useful and widespread applied relation between the 
expected standard deviation under reproducibility conditions, σH and the concentration, c. It expresses 
inter-laboratory precision expected in inter-laboratory trials. Therefore, this relation is suitable for 
calculating the target standard deviation, σp in inter-laboratory trials. 
Thompson [11] demonstrated that this Horwitz equation is not applicable to the lower concentration 
range (<120 µg/kg) as well as at high concentrations (>138 g/kg). Therefore a complementary model is 
suggested: 
 
For analyte concentrations <120 µg/kg: 
c22.0σH =      
 
For analyte concentrations >138 g/kg: 
5.0
H c01.0σ =  
 
 where σH  = expected standard deviation in inter-laboratory trials; 
  c = concentration of the analyte. 
  
The target standard deviation, σp, was determined using the equation for analyte concentrations <120 
µg/kg, with c = the assigned value and σH = σp . 
4.4 Performance characteristics with regard to the accuracy 
For illustrating the performance of the participating laboratories with regard to the accuracy, a za-score 
is calculated. For the evaluation of the performance of the laboratories, the Guidelines of ISO/IEC 
Guide 43-2 [4] and ISO/DIS 13528 [12] are applied. According to these guidelines, za-scores are 
classified as presented in table 2.  
 
Table 2: Classification of z-scores 
z ≤ 2 satisfactory 
2 < z < 3 questionable 
z ≥ 3 unsatisfactory 
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When the calculated uncertainty of the assigned value complies with the criterion mentioned in § 4.2, 
the uncertainty is negligible. In this case the accuracy z-score is calculated from: 
 
p
a σ
Xx
z
-
=  
 
 where za  = accuracy z-score; 
   x = mean result of the laboratory; 
   X = assigned value; 
σp  = target standard deviation. 
 
However, if the uncertainty of the assigned value exceeds the value mentioned in § 4.2, it could 
influence the evaluation of the laboratories. Therefore this uncertainty is taken into account by 
calculating a za-score [13]: 
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u
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σ
 
 
 where za = accuracy z-score taking into account the uncertainty of the uncertainty; 
   x = mean result of the laboratory; 
   X = assigned value; 
σp  = target standard deviation; 
u = uncertainty of the assigned value. 
 
4.5 Performance characteristics with regard to the reproducibility  
In addition to the evaluation of the accuracy, it is useful to inform the participants about the 
reproducibility of the results.  
In the design of this inter-laboratory study, two unidentified duplicate samples each material were 
submitted to the participants. Therefore, every laboratory reported two pairs of results for each material. 
From the results of the blind pairs of material B and C the repeatability (sr) and the within-lab-
reproducibility ( ) were calculated [19]. 
LRs
 
The repeatability standard deviation is calculated from: 
 
p2
d
s
2
i
r
∑
=  
  
 where sr = repeatability standard deviation; 
   di = difference between the individual values for a pair; 
   p = number of pairs. 
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The within-lab-reproducibility standard deviation is calculated from: 
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 where s = within-lab-reproducibility standard deviation; 
LR
   sr = repeatability standard deviation; 
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    where Ti = sum of the individual values for the pair; 
     T = mean of the Ti across all pairs; 
     p = number of pairs. 
 
To inform a laboratory about the performance regarding the reproducibility, the Horwitz-ratio 
(HORRAT) is a suitable value [20]. In this report, the Horwitz ratio is calculated from the within-lab 
reproducibility, because it is not possible to calculate a reproducibility standard deviation from the 
laboratory data. The reproducibility (sR ) includes inter-laboratory variation and must therefore always 
be higher than the within-lab reproducibility ( ).  
LR
s
Because the HORRAT value is calculated from instead of s
LR
s R, this value is not for evaluation purposes 
but for information only.  
 
The HORRAT is calculated from: 
 
pσ
s
HORRAT L
R
=  
 
 where HORRAT  = Horwitz ratio; 
LRs = within-lab reproducibility standard deviation; 
   σp = target standard deviation (§ 4.3). 
 
In this formula, a HORRAT value equal to 1.0 indicates that the within-lab reproducibility is equal to the 
predicted maximum reproducibility standard deviation resulting from the Horwitz equation. However, 
the latter refers to reproducibility between laboratories and, hence, would normally be higher than the 
within-lab reproducibility. Therefore it is within reason that the HORRAT value calculated from the 
within-lab reproducibility, as done in this report, should be substantially below 1.0.  
Nonetheless in this report, a HORRAT value is not regarded as a questionable result unless it exceeds 
1.0. 
4.6 Calculation of laboratory performance scores 
In the evaluation of this proficiency test a score is calculated to demonstrate the performance of the 
participating laboratories. This score accounts for the accuracy and reproducibility of the results, and the 
occurrence of false positive and false negative results.  
For each satisfactory result regarding the accuracy (|za-score|<2.0) and for each satisfactory result 
regarding the reproducibility (HORRAT<1.0), 1 point is earned. For each false positive or false negative 
result per material, 1 point is subtracted from the score. The maximum attainable score is 8. 
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5 RESULTS AND DISCUSSION 
Sixteen out of seventeen invited laboratories subscribed for the participation in the inter-laboratory 
study for tetracyclines in poultry muscle. Ten laboratories managed to submit valid results before the 
dead-line of the 1st of June. Laboratory 16 reported their results on the 27th of June. It is noted that no 
statement can be made regarding the stability of the materials over the period after the dead-line. 
Nevertheless, these results were included in the report.  
Five laboratories were not able to report data due to different causes.  
The majority of laboratories analysed the samples in duplicate. The laboratories 1 and 16 reported only 
one result per sample. The number of laboratories included in the statistical evaluation is 11 for 4-
epiOTC and OTC and 9 for DC. 
All results are presented as reported by the laboratories, without any correction. 
5.1 Evaluation of the results of material A 
Material A is a blank sample. Each laboratory received two randomly coded blank samples, which were 
not identified as such. Laboratory 5 detected OTC in both samples originating from material A. The 
identity of the analyte was confirmed by LCMS/MS. This result is considered as a false positive result. 
None of the other participants detected any tetracycline residues in the samples originating from 
material A.  
An overview of false negative and false positive results is presented in appendix VII. 
5.2 Evaluation of the results of material B 
Eleven participants reported results for the samples originating from material B. Laboratory 1 and 16 
reported only a single value for both samples. Laboratory 3 and 7 did not include DC in their analyses 
and were therefore not able to report any values for this analyte. 
No false negative or false positive results were reported.  
 
The assigned value and the uncertainty of the assigned value were calculated according to § 4.1 and § 
4.2. 
The uncertainty of the assigned value of 4-epiOTC + OTC for material B exceeds 0.3σp (§4.2). 
Therefore, for this material, the uncertainty of the assigned value is taken into account with regard to the 
evaluation of the laboratories. The za-scores and HORRAT values for 4-epiOTC + OTC obtained by 
each laboratory were calculated. The results are presented in appendix VIII.  Graphical representations 
of the za-scores and HORRAT values are included. 
 
The uncertainty of the assigned value of DC for material B is below 0.3σp (§4.2). Therefore, the 
uncertainty of the assigned value is considered to be negligible. The za-scores and HORRAT values for 
DC obtained by each laboratory were calculated. The results are presented in appendix IX. Graphical 
representations of the za-scores and HORRAT values are included. 
 
The quantitative results of all of the laboratories were satisfactory regarding the accuracy. Surprisingly, 
no correlation was found between low results and laboratories that did not include 4epi-OTC in their 
analysis. The number of satisfactory za-scores for both analytes is presented in table 3. 
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The calculation of the HORRAT value results in a value above 1.0 for laboratory 5 for 4-epiOTC + 
OTC. This indicates questionable performance of the applied method with regard to repeatability. No 
HORRAT value could be calculated for laboratory 1 and 16, because only one result per sample was 
reported. 
 
Table 3. Number and percentage of satisfactory za-scores for material B. 
Analyte No. of 
satisfactory 
za-scores 
% of 
satisfactory 
za-scores 
No. of 
satisfactory 
HORRAT values 
% of 
satisfactory 
HORRAT values 
4-epiOTC+OTC 11 of 11 100% 8 of 9 89% 
DC 9 of 9 100% 7 of 7  100% 
 
Some laboratories report relatively small values for CCα. The CCα reported by laboratories are 
compared to the reproducibility calculated from the results in this inter-laboratory study. This 
comparison could not be made for laboratory 1 and 16 due to the lack of a duplicate analysis. 
Laboratory 1, however, reports surprisingly low CCα and CCß compared to the other participants. 
For laboratories 5 and 12, the reproducibility for 4epiOTC + OTC is higher than is suggested by the 
reported CCα for this analyte. For laboratory 9 the reproducibility for DC is higher than is suggested by 
the reported CCα for this analyte.  
5.3 Evaluation of the results of material C 
Eleven participants reported results for the samples originating from materials C. Laboratory 1 and 16 
reported only a single value for each sample. Laboratory 6 did not detect any tetracycline residues in 
sample TETRA/2005/088 originating from material C. In both samples originating from material A, also 
no tetracycline residues were found. This excludes a switch of samples. This result is considered as a 
false negative result.  
No other false negative or false positive results were reported. 
An overview of false negative and false positive results is presented in appendix VII. 
 
The uncertainty of the assigned value of 4-epiOTC + OTC for material C exceeds 0.3σp (§4.2). 
Therefore, for this material, the uncertainty of the assigned value is taken into account with regard to the 
evaluation of the laboratories. The za-scores and HORRAT values for OTC obtained by each laboratory 
were calculated. The results are presented in appendix X. Graphical representations of the za-scores and 
HORRAT values are included. 
 
The uncertainty of the assigned value of DC for material C is below 0.3σp (§4.2). Therefore, the 
uncertainty of the assigned value is considered to be negligible. The za-scores and HORRAT values for 
DC obtained by each laboratory were calculated. The results are presented in appendix XI. Graphical 
representations of the za-scores and HORRAT values are included. 
 
The results of almost all of the laboratories were satisfactory regarding accuracy. The number of 
satisfactory za -scores for both of the analytes is presented in table 4. 
 
All calculated HORRAT values were considered satisfactory.  No HORRAT value could be calculated for 
laboratory 1, 6 and 16, because only one result per sample was reported. 
Table 4. Number and percentage of satisfactory z-scores for material C.  
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Analyte No. of 
satisfactory 
za-scores 
% of 
satisfactory 
za-scores 
No. of 
satisfactory 
HORRAT values 
% of 
satisfactory 
HORRAT values 
OTC 9 of 11 82% 8 of 8 100% 
DC 9 of 9 100% 6 of 6 100% 
 
Some laboratories report relatively small values for CCα. The CCα reported by laboratories are 
compared to the reproducibility calculated from the results in this inter-laboratory study. This 
comparison could not be made for laboratory 1 and 16 due to the lack of a duplicate analysis. 
For laboratory 5 the reproducibility for OTC is higher than is suggested by the reported CCα for this 
analyte. 
5.4 Laboratory scores 
The performance of each participating laboratory is expressed in a laboratory performance score (§4.6). 
The maximum attainable score is 8 points. In case DC is not included in the method or only a single 
value for each sample was reported, the maximum attainable score is lower. The laboratory performance 
score and the maximum attainable score per lab are presented in appendix XII. 
From the 11 laboratories 8 (i.e. 72%) showed optimal performance for the analysis of tetracyclines in 
poultry muscle regarding the accuracy, the repeatability and the occurrence of false positive and false 
negative samples,.  
RIKILT Report number 2005.007 18
6 CONCLUSION 
Seventeen laboratories were invited to participate in the inter-laboratory study for tetracyclines in 
poultry muscle, of which sixteen laboratories subscribed.  
Ten laboratories reported their results within the given timescale. One laboratory reported their results 
with a delay of 23 days. All reported results were included in the report. 
 
Three laboratories did not report a value for CCα and CCß. Apparently some laboratories are not yet 
ready to comply with the requirements of Commission Decision 2002/657/EC [16] regarding CCα and 
CCß that apply for registered veterinary drugs as from the 1st of August 2007. 
Some laboratories report relatively low values for CCα, suggesting good method reproducibility. One 
laboratory reports relatively high values for CCα for DC, indicating variable method performance for 
this compound.  
The results regarding the reproducibility of some laboratories in this inter-laboratory study in some 
cases indicate higher reproducibility than is suggested by the reported CCα. In those cases, the accuracy 
of the reported CCα can be doubted.  
 
Only four of the participating laboratories include 4-epiOTC, 4-epiTC and 4-epiCTC in their analysis, 
as stated in the Commission Regulation No. 281/96 [10]. The laboratories that have these 4-
epitetracyclines included in their method cope in different ways regarding the quantification of these 
analytes.  
 
One laboratory found OTC residues in a significant amount in the samples originating from the blank 
material. The identity of the analyte was confirmed by the laboratory. This is considered as a false 
positive result. 
 
The calculated assigned value of material B is 104 µg/kg 4-epiOTC + OTC and 53 µg/kg DC, with an 
uncertainty of 12 µg/kg and 1.4 µg/kg respectively. The uncertainty of the assigned value of 4-epiOTC 
+ OTC in this material is quit high (above 0.3σp). 
Although, all participants reported satisfactory results with regard to the accuracy, it must be noted that 
a considerable variation for the reported amount of 4-epiOTC + OTC is observed (average results 
ranging from 63.5 to 146.7 µg/kg).   
One laboratory reported results with a questionable reproducibility.  
No false positive or false negative results were repported for material B. 
 
The calculated assigned value of material C is 141 µg/kg OTC and 181 µg/kg DC, with an uncertainty 
of 10 µg/kg for both analytes. The uncertainty of the assigned value of OTC in this material is quit high 
(above 0.3σp). 
82% of the participants reported satisfactory results with regard to the accuracy of OTC. A considerable 
variation is observed for the reported amount of OTC in this material (average results ranging from 85.5 
to 231.5 µg/kg).   
For DC, all laboratories reported satisfactory results.  
One laboratory did not detect any tetracycline residues in material C. This was considered as a false 
negative result. No other false positive or false negative results were reported for material C. 
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The performance regarding accuracy, reproducibility, false positives and false negatives was expressed 
in a laboratory performance score for each laboratory. 72% of the laboratories obtained the maximum 
score. 
 
Although most laboratories obtained satisfactory results regarding the accuracy and the reproducibility, 
it is concluded that extra effort is needed regarding the analysis of tetracyclines in poultry muscle: 
• 4-epiOTC, 4-epiTC and 4-epiCTC should be included in the method for the analysis of 
tetracyclines by all laboratories; 
• Reconsideration of values determined for CCα and CCß with respect to their accuracy may be 
necessary in some cases; 
• An effort should be made regarding the quantitative analysis of especially OTC in poultry 
muscle; 
• Some laboratories should make an effort to prevent false positives and false negatives in the 
future. 
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APPENDIX I: Codification of the samples 
 
 
Set No. Material A Material B Material C 
1 TETRA/2005/068 TETRA/2005/095 TETRA/2005/049 
 TETRA/2005/109 TETRA/2005/030 TETRA/2005/059 
2 TETRA/2005/112 TETRA/2005/128 TETRA/2005/144 
 TETRA/2005/004 TETRA/2005/082 TETRA/2005/132 
3 TETRA/2005/146 TETRA/2005/036 TETRA/2005/001 
 TETRA/2005/005 TETRA/2005/023 TETRA/2005/083 
4 TETRA/2005/002 TETRA/2005/011 TETRA/2005/057 
 TETRA/2005/107 TETRA/2005/029 TETRA/2005/008 
5 TETRA/2005/006 TETRA/2005/007 TETRA/2005/126 
 TETRA/2005/085 TETRA/2005/025 TETRA/2005/051 
6 TETRA/2005/120 TETRA/2005/079 TETRA/2005/092 
 TETRA/2005/110 TETRA/2005/140 TETRA/2005/088 
7 TETRA/2005/040 TETRA/2005/087 TETRA/2005/037 
 TETRA/2005/041 TETRA/2005/043 TETRA/2005/106 
8 TETRA/2005/034 TETRA/2005/084 TETRA/2005/104 
 TETRA/2005/105 TETRA/2005/116 TETRA/2005/108 
9 TETRA/2005/123 TETRA/2005/035 TETRA/2005/131 
 TETRA/2005/101 TETRA/2005/046 TETRA/2005/050 
10 TETRA/2005/100 TETRA/2005/015 TETRA/2005/145 
 TETRA/2005/130 TETRA/2005/016 TETRA/2005/133 
11 TETRA/2005/013 TETRA/2005/058 TETRA/2005/142 
 TETRA/2005/062 TETRA/2005/135 TETRA/2005/027 
12 TETRA/2005/134 TETRA/2005/121 TETRA/2005/143 
 TETRA/2005/042 TETRA/2005/010 TETRA/2005/096 
13 TETRA/2005/147 TETRA/2005/076 TETRA/2005/021 
 TETRA/2005/091 TETRA/2005/115 TETRA/2005/056 
14 TETRA/2005/127 TETRA/2005/064 TETRA/2005/071 
 TETRA/2005/136 TETRA/2005/089 TETRA/2005/054 
15 TETRA/2005/024 TETRA/2005/111 TETRA/2005/048 
 TETRA/2005/039 TETRA/2005/077 TETRA/2005/019 
16 TETRA/2005/033 TETRA/2005/094 TETRA/2005/137 
 TETRA/2005/044 TETRA/2005/124 TETRA/2005/148 
17 TETRA/2005/061 TETRA/2005/117 TETRA/2005/065 
 TETRA/2005/075 TETRA/2005/067 TETRA/2005/022 
18 TETRA/2005/099 TETRA/2005/129 TETRA/2005/081 
 TETRA/2005/113 TETRA/2005/055 TETRA/2005/028 
19 TETRA/2005/078 TETRA/2005/032 TETRA/2005/017 
 TETRA/2005/026 TETRA/2005/119 TETRA/2005/098 
20 TETRA/2005/014 TETRA/2005/114 TETRA/2005/072 
 TETRA/2005/060 TETRA/2005/090 TETRA/2005/102 
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APPENDIX IIa: Statistical evaluation of homogeneity data of material B for OTC + 4-epiOTC 
 
 OTC + 4-epiOTC (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 131 133 
2 130 140 
3 127 156 
4 128 128 
5 129 123 
6 115 130 
7 127 138 
8 126 123 
9 124 130 
10 127 115 
Grand mean 129 
Cochrans test   
C 0.527 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 28.1 
san2 78.1 
ssam2 0.0 
σall2 71.0 
critical 212.4 
Ssam2 < critical? ACCEPT 
  
No 4-epiTC, TC, 4epi-CTC or CTC was detected in the samples (LoD=10 µg/kg).  
 
san2 = estimate of analytical variance; 
ssam2 = estimate of sampling variance; 
σall2 = allowable sampling variance. 
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APPENDIX IIb: Statistical evaluation of homogeneity data of material B for DC 
 
 DC (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 58 59 
2 58 66 
3 61 63 
4 58 59 
5 60 61 
6 55 58 
7 58 55 
8 58 59 
9 63 58 
10 57 47 
Grand mean 58 
Cochrans test   
C 0.435 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz <120 ppb: 12.8 
san2 10.8 
ssam2 3.6 
σall2 14.8 
critical 38.8 
Ssam2 < critical? ACCEPT 
  
No 4-epiTC, TC, 4epi-CTC or CTC was detected in the samples (LoD=10 µg/kg).  
 
san2 = estimate of analytical variance; 
ssam2 = estimate of sampling variance; 
σall2 = allowable sampling variance. 
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APPENDIX IIIa: Statistical evaluation of homogeneity data of material C for OTC  
 
 OTC (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 150 153 
2 152 156 
3 140 151 
4 156 161 
5 168 154 
6 155 148 
7 144 163 
8 158 148 
9 160 132 
10 144 151 
Grand mean 152 
Cochrans test   
C 0.455 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 32.3 
san2 82.4 
ssam2 0.0 
σall2 94.0 
critical 259.9 
Ssam2 < critical? ACCEPT 
  
No 4epi-OTC, 4-epiTC, TC, 4epi-CTC or CTC was detected in the samples (LoD=10 µg/kg).  
 
san2 = estimate of analytical variance; 
ssam2 = estimate of sampling variance; 
σall2 = allowable sampling variance. 
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APPENDIX IIIb: Statistical evaluation of homogeneity data of material C for DC 
 
 DC (µg/kg) 
Sample No. Replicate 1 Replicate 2 
1 205 210 
2 215 225 
3 192 184 
4 207 189 
5 206 201 
6 190 188 
7 181 190 
8 178 186 
9 199 171 
10 190 195 
Grand mean 195 
Cochrans test   
C 0.499 
Ccrit 0.602 
C < Ccrit? NO OUTLIERS 
Target sd (σp) Horwitz: 42.9 
san2 73.6 
ssam2 107.2 
σall2 143.4 
critical 343.9 
Ssam2 < critical? ACCEPT 
  
No 4-epiOTC, 4-epiTC, TC, 4epi-CTC or CTC was detected in the samples (LoD=10 µg/kg).  
 
san2 = estimate of analytical variance; 
ssam2 = estimate of sampling variance; 
σall2 = allowable sampling variance.  
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APPENDIX IVa: Statistical evaluation of stability data of material B  
 
Statistical evaluation for 4-epiOTC + OTC 
Date of 
analysis 
Time 
(days) 
4-epiOTC + 
OTC (µg/kg) 
Pooled 
st. dev 
(µg/kg) 
t tcrit t < tcrit 
03/07/2005 0 129     
05/17/2005 71 132 10.9 0.43 2.08 ACCEPT 
05/31/2005 85 135 10.9 0.83 2.08 ACCEPT 
 
Statistical evaluation for DC 
Date of 
analysis 
Time 
(days) 
DC (µg/kg) Pooled 
st. dev 
(µg/kg) 
t tcrit t < tcrit 
03/07/2005 0 55     
05/17/2005 71 57 7.5 0.52 2.08 ACCEPT 
05/31/2005 85 59 7.5 0.92 2.08 ACCEPT 
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APPENDIX IVb: Statistical evaluation of stability data of material C  
 
Statistical evaluation for OTC 
Date of 
analysis 
Time 
(days) 
OTC (µg/kg) St. dev 
(µg/kg) 
t tcrit t < tcrit 
03/07/2005 0 152     
05/17/2005 71 146 12.7 0.84 2.08 ACCEPT 
05/31/2005 85 138 12.7 1.77 2.08 ACCEPT 
 
Statistical evaluation for DC 
Date of 
analysis 
Time 
(days) 
DC (µg/kg) St. dev 
(µg/kg) 
t tcrit t < tcrit 
03/07/2005 0 195     
05/17/2005 71 202 26.8 0.44 2.08 ACCEPT 
05/31/2005 85 214 27.0 1.16 2.08 ACCEPT 
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APPENDIX V: Overview of the applied methods 
Lab 
code 
Extraction Sample purification Internal standard Detection 
method 
Compound analysed 
for 
4-epiOTC and 
OTC separated? 
Quantification 
of 4-epiOTC 
2002/657/EC 
applied? 
Lab1 
 
EDTA-McIlvain, pH=4.0 Filter, 
SPE: OASIS® HLB 
- LCUV OTC, TC, CTC, DC 
LCMS/MS 
  Yes 
Lab2 Sodium succinate (0.1 M), 
pH=4.0 
Filter, 
SPE: OASIS® HLB 
demeclocycline     
       
        
         
      
      
     
   
  
      
LCMS/MS OTC, TC, CTC, DC
and 4-epimers 
Yes Separate
quantification 
Yes 
Lab3 EDTA-McIlvain Filter, SPE: C18 - LCDAD OTC, TC, CTC No
Lab5 PBS-EDTA buffer / 
acetonitrile 
Filter - LCMS/MS OTC, TC, CTC, DC Yes
Lab6 McIlvain Filter,
SPE: OASIS® HLB 
- LCMS/MS OTC, TC, CTC, DC
and 4-epiCTC 
 No Sum quantified Yes
Lab7 EDTA-McIlvain, pH=4.0 SPE: C18 - LCDAD OTC No
Lab8 EDTA-McIlvain (0.1 M), 
pH=4.0 
Filter, 
SPE: OASIS® HLB 
demeclocycline LCMS/MS OTC, TC, CTC, DC
and 4-epimers 
Yes Sum quantified Yes
Lab9 NM Chelating sepharose column 
with copper ions, 
SPE: polymer based 
- LCUV OTC, TC, CTC, DC
and 4-epimers 
 No Sum quantified Yes
Lab10 TCA 5% Filter tetracycline LCMS/MS OTC, TC, CTC, DC 
and 4-epiOTC 
No Sum quantified Yes
Lab12 EDTA-McIlvain (0.1 M) SPE: OASIS® HLB - LCMS/MS OTC, TC, CTC, DC 
and 4-epimers 
Yes Separate
quantification 
Yes 
Lab 16 Acetonitrile / heptane with 
0.15% formic acid 
Evaporation of acetonitril, 
SPE: OASIS® HLB 
demeclocycline LCMS/MS OTC, TC, CTC, DC Yes
NM = not mentioned 
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APPENDIX VI:  Overview of method characteristics 
 
 4-epiOTC OTC DC 
Lab code CCα 
(µg/kg) 
CCß 
(µg/kg) 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
CCα 
(µg/kg) 
CCß 
(µg/kg) 
Lab1   104.3 108.6 103.5 106.9 
Lab2 122.9 147.1 124.2 144.4 118.5 135.4 
Lab3       
Lab5   115 129 129 158 
Lab6       
Lab7       
Lab8   115 130 125 154 
Lab9   112 126 119 146 
Lab10   111 121 153 206 
Lab12 113 137 107 120 112 133 
Lab 16       
 
 
 4-epiOTC OTC DC 
Lab code LoD 
(µg/kg) 
LoQ 
(µg/kg) 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
LoD 
(µg/kg) 
LoQ 
(µg/kg) 
Lab1       
Lab2 0.21 10 0.15 10 2.5 10 
Lab3   50 50   
Lab5       
Lab6   8 25 2 10 
Lab7   25 50   
Lab8       
Lab9       
Lab10       
Lab12       
Lab 16       
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APPENDIX VII: Overview of false positive and false negative results 
 
False positive results 
Lab code Sample code Material Analyte 
found 
Replicate 1 
(µg/kg) 
Replicate 2 
(µg/kg) 
Lab5 TETRA/2005/006 A OTC 113 40 
 TETRA/2005/085 A OTC 46 52 
 
False negative results 
Lab code Sample code Material Analyte 
Lab6 TETRA/2005/088 C OTC 
 TETRA/2005/088 C DC 
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APPENDIX VIII: The result for the analysis of 4-epiOTC+OTC in poultry muscle (material B) 
 
4-epiOTC + OTC 
Assigned value 104.0 µg/kg 
Uncertainty of assigned value 12.0 µg/kg 
Target standard deviation (Horwitz, Thompson) 22.9 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average sr LRs  za-score HORRAT 
Lab1 65  62  63.5   -1.6  
Lab2 138.1 130.6 135.9 127.6 133.1 5.6 4.4 1.1 0.2 
Lab3 152.7 141.5 139.9 129.9 141 7.5 10.1 1.4 0.4 
Lab5 132 110 176 154 143 15.6 33.0 1.5 1.4 
Lab6 64 56 67 70 64.3 4.3 6.7 -1.5 0.3 
Lab7 98.8 101.1 97 101.5 99.6 2.5 1.9 -0.2 0.1 
Lab8 110 119 119 121 117.3 4.6 5.1 0.5 0.2 
Lab9 62 62 65 68 64.3 1.5 3.4 -1.5 0.1 
Lab10 104.1 99 96.5 100.4 100 3.2 3.2 -0.2 0.1 
Lab12 141.1 142.3 149 154.5 146.7 2.8 7.4 1.7 0.3 
Lab 16 70  73  71.5   -1.3  
The bold values indicate a questionable performance (HORRAT>1) 
 
Figure VIIIa: Graphical representation of the reported results 
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Figure VIIIb: Graphical representation of za-score Figure VIIIc: Graphical representation of HORRAT  
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APPENDIX IX: The result for the analysis of DC in poultry muscle (material B) 
 
DC 
Assigned value 53.3 µg/kg 
Uncertainty of assigned value 1.4 µg/kg 
Target standard deviation (Horwitz, Thompson) 11.8 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average sr LRs  za-score HORRAT 
Lab1 55.7  52.9  54.3   0.1  
Lab2 55.6 57.6 54.4 58.3 56.5 2.2 1.6 0.3 0.1 
Lab5 46 54 53 61 53.5 5.7 6.4 0.0 0.5 
Lab6 41 36 44 52 43.3 4.7 7.5 -0.9 0.6 
Lab8 59 58 58 60 58.8 1.1 0.9 0.5 0.1 
Lab9 44 50 65 57 54.0 5.0 10.5 0.1 0.9 
Lab10 44.6 42.7 38.2 37.4 40.7 1.0 4.2 -1.1 0.4 
Lab12 52.5 57.9 57.9 57 56.3 2.7 2.5 0.3 0.2 
Lab16 56  39  47.5   -0.5  
 
Figure IXa: Graphical representation of the reported results 
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Figure IXb: Graphical representation of za-score Figure IXc: Graphical representation of HORRAT  
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APPENDIX X: The result for the analysis of OTC in poultry muscle (material C) 
 
OTC 
Assigned value 140.7 µg/kg 
Uncertainty of assigned value 9.6 µg/kg 
Target standard deviation (Horwitz) 30.2 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average sr LRs  za-score HORRAT 
Lab1 144.4  131.1  137.8   -0.1  
Lab2 128.2 116.1 129.7 126.7 125.2 6.2 6.1 -0.5 0.2 
Lab3 194.9 189.8 168.7 186.9 185.1 9.5 12.3 1.4 0.4 
Lab5 250 242 236 198 231.5 19.4 24.7 2.9 0.8 
Lab6   78 93 85.5   -1.7  
Lab7 235.2 242 228 235.3 235.1 5.0 6.0 3.0 0.2 
Lab8 146 161 165 148 155.0 11.3 8.3 0.5 0.3 
Lab9 138 151 158 156 150.8 6.6 10.0 0.3 0.3 
Lab10 124.4 126.4 120.6 117 122.1 2.1 4.9 -0.6 0.2 
Lab12 107.5 99.3 101.1 97 101.2 4.6 4.5 -1.2 0.2 
Lab 16 129  134  131.5   -0.3  
The bold values indicate a questionable performance (|z|>2) 
 
Figure Xa: Graphical representation of the reported results 
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Figure Xb: Graphical representation of za-score Figure Xc: Graphical representation of HORRAT  
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APPENDIX XI: The result for the analysis of DC in poultry muscle (material C) 
 
DC  
Assigned value 180.5 µg/kg 
Uncertainty of assigned value 9.7 µg/kg 
Target standard deviation (Horwitz) 37.4 µg/kg 
Code Replicate 1 Replicate 2 Replicate 3 Replicate 4 Average  sr LRs  za-score HORRAT 
Lab1 205  183.9  194.5   0.4  
Lab2 205.9 186.9 189.4 186.2 192.1 9.6 9.1 0.3 0.2 
Lab5 169 168 175 167 169.8 4.0 3.4 -0.3 0.1 
Lab6   143 162 152.5   -0.8  
Lab8 218 240 218 220 224.0 11.0 10.5 1.2 0.3 
Lab9 186 178 197 206 191.8 6.0 14.4 0.3 0.4 
Lab10 128.7 142.9 157 154.8 145.9 7.2 15.1 -0.9 0.4 
Lab12 195.8 200.3 197.3 195.8 197.3 2.4 2.0 0.5 0.1 
Lab16 134  183  158.5   -0.6  
 
Figure XIa: Graphical representation of the reported results 
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Figure XIb: Graphical representation of za-score Figure XIc: Graphical representation of HORRAT  
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APPENDIX XII: The calculation of the laboratory performance score 
  
False 
 
False 
Material B  
accuracy / 
reproducibility 
Material C  
accuracy / 
reproducibility 
  
Code positives negatives OTC DC OTC DC Total Maximum
Lab1   1 / - 1 / - 1 / - 1 / - 4 4* 
Lab2   1 / 1 1 / 1 1 / 1 1 / 1 8 8 
Lab3   1 / 1 - / -  1 / 1 - / - 4 4* 
Lab5 -1  1 / 0 1 / 1 0 / 1 1 / 1 5 8 
Lab6  -2 1 / 1 1 / 1 1 / - 1 / - 4 6** 
Lab7   1 / 1 - / - 0 / 1 - / - 3 4* 
Lab8   1 / 1 1 / 1 1 / 1 1 / 1 8 8 
Lab9   1 / 1 1 / 1 1 / 1 1 / 1 8 8 
Lab10   1 / 1 1 / 1 1 / 1 1 / 1 8 8 
Lab12   1 / 1 1 / 1 1 / 1 1 / 1 8 8 
Lab 16   1 / 1 1 / 1 1 / 1 1 / 1 8 8 
The bold figures indicate laboratories that obtained the maximum attainable laboratory performance score.  
 
*  No HORRAT value could be calculated, because only one result per sample was reported. 
**  Because of the false negative result for material C, no HORRAT value could be calculated for this material. 
 
 
 
